Transgene Biotek Ltd

Transgene Biotek Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Transgene Biotek Ltd

₹ 4.75 0.42%
04 Jul 11:01 a.m.
transgenebiotek.com BSE: 526139
About

Incorporated in 1990, Transgene Biotek Limited is in the business of Research & Development of Pharmaceutical products. The registered office of the company is in Telangana.[1]

Key Points

Business Expertise:[1]
Company is in production and oral formulation of different proteins using TrabiORAL technology
a) Oncology[2]
b) Auto Immunity[3]
c) Drug Delivery[4]
d) Biogenerics[5]

Website BSE
  • Market Cap ₹ 36.0 Cr.
  • Current Price ₹ 4.75
  • High / Low ₹ 10.8 / 3.22
  • Stock P/E
  • Book Value ₹ -1.00
  • Dividend Yield 0.00 %
  • ROCE -6.11 %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 23.6%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
0.09 0.06 0.00 0.00 0.00 0.10 0.05 0.05 0.05 0.05 0.06 0.08 0.08
0.14 0.20 0.52 0.13 0.22 0.22 0.17 0.16 0.32 0.46 0.13 0.17 0.62
Operating Profit -0.05 -0.14 -0.52 -0.13 -0.22 -0.12 -0.12 -0.11 -0.27 -0.41 -0.07 -0.09 -0.54
OPM % -55.56% -233.33% -120.00% -240.00% -220.00% -540.00% -820.00% -116.67% -112.50% -675.00%
0.08 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.05 0.65 0.04 0.04 0.04
Interest 0.06 0.05 0.05 0.05 0.05 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.19
Depreciation 2.51 1.24 1.24 1.24 1.24 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02
Profit before tax -2.54 -1.39 -1.77 -1.38 -1.47 -0.13 -0.13 -0.12 -0.27 0.20 -0.07 -0.09 -0.71
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-2.54 -1.39 -1.77 -1.38 -1.47 -0.13 -0.13 -0.12 -0.27 0.20 -0.07 -0.09 -0.71
EPS in Rs -0.34 -0.18 -0.23 -0.18 -0.19 -0.02 -0.02 -0.02 -0.04 0.03 -0.01 -0.01 -0.09
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.97 0.30 0.18 0.28 0.12 0.07 0.00 0.17 0.09 0.06 0.23 0.26
2.79 1.81 1.32 2.84 5.12 0.75 0.87 0.70 0.55 0.68 0.83 1.38
Operating Profit -1.82 -1.51 -1.14 -2.56 -5.00 -0.68 -0.87 -0.53 -0.46 -0.62 -0.60 -1.12
OPM % -187.63% -503.33% -633.33% -914.29% -4,166.67% -971.43% -311.76% -511.11% -1,033.33% -260.87% -430.77%
-114.37 0.01 0.17 0.66 10.27 2.04 0.18 0.27 0.21 0.18 0.18 0.78
Interest 0.00 0.36 0.07 0.43 1.03 0.26 0.38 0.27 0.23 0.62 0.14 0.24
Depreciation 17.22 17.18 20.50 17.53 9.89 9.89 9.90 9.91 9.92 4.95 0.09 0.09
Profit before tax -133.41 -19.04 -21.54 -19.86 -5.65 -8.79 -10.97 -10.44 -10.40 -6.01 -0.65 -0.67
Tax % 0.00% 0.00% 0.00% 0.00% 13.98% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-133.40 -19.04 -21.54 -19.86 -6.44 -8.79 -10.96 -10.43 -10.40 -6.01 -0.66 -0.68
EPS in Rs -17.61 -2.51 -2.84 -2.62 -0.85 -1.16 -1.45 -1.38 -1.37 -0.79 -0.09 -0.09
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -1%
5 Years: %
3 Years: 42%
TTM: 13%
Compounded Profit Growth
10 Years: 7%
5 Years: 14%
3 Years: 25%
TTM: -3%
Stock Price CAGR
10 Years: 6%
5 Years: -5%
3 Years: 11%
1 Year: -46%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 75.77 75.77 75.77 75.77 75.77 75.77 75.77 75.77 75.77 75.77 75.77 75.77
Reserves 121.41 102.38 78.89 -34.48 -40.92 -49.71 -60.67 -71.11 -75.97 -81.98 -82.64 -83.34
13.06 14.34 15.28 16.01 9.84 9.14 10.33 11.33 12.02 13.12 14.00 14.52
139.21 137.84 123.15 30.88 31.97 31.45 31.43 31.01 25.40 25.57 25.31 27.25
Total Liabilities 349.45 330.33 293.09 88.18 76.66 66.65 56.86 47.00 37.22 32.48 32.44 34.20
180.58 163.40 140.95 61.16 50.97 41.10 31.20 21.32 11.40 6.45 6.36 9.83
CWIP 0.29 0.29 0.29 2.04 1.87 1.87 1.87 1.87 1.87 1.87 1.87 0.00
Investments 92.20 92.20 92.20 0.00 0.00 0.00 0.00 0.01 0.11 0.11 0.10 0.10
76.38 74.44 59.65 24.98 23.82 23.68 23.79 23.80 23.84 24.05 24.11 24.27
Total Assets 349.45 330.33 293.09 88.18 76.66 66.65 56.86 47.00 37.22 32.48 32.44 34.20

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-2.11 -0.95 0.02 0.02 -0.63 -1.74 0.14 0.01 0.10 0.00 0.00 1.20
1.46 -0.02 -0.02 0.00 3.05 1.74 0.00 -0.04 -0.10 -0.01 0.00 -1.70
0.60 0.94 0.00 0.00 -2.37 0.00 -0.20 0.00 0.00 0.00 0.00 0.78
Net Cash Flow -0.05 -0.02 0.00 0.02 0.05 0.00 -0.06 -0.02 0.00 -0.01 0.00 0.28

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 6,867.27 19,941.17 3,305.28 13.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Days 106.46 365.00 365.00 1,460.00 121.67 156.43
Days Payable 25,975.83 5,018.75 3,528.33 13,870.00 1,460.00 1,199.29
Cash Conversion Cycle -19,002.11 19,941.17 3,305.28 13.04 -4,653.75 -3,163.33 -1,338.33 0.00 -1,042.86 0.00 0.00
Working Capital Days 692.37 1,533.00 2,331.94 -1,733.75 -21,413.33 -35,717.86 -14,277.94 -4,785.56 -6,995.83 -1,634.57 -4,562.50
ROCE % -6.58% -9.27% -11.85% -17.10% -14.75% -25.79% -34.93% -49.11% -73.14% -57.55% -7.26% -6.11%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
23.64% 23.64% 23.64% 23.64% 23.64% 23.64% 23.64% 23.64% 23.64% 23.64% 23.64% 23.64%
76.36% 76.37% 76.36% 76.36% 76.37% 76.37% 76.36% 76.36% 76.36% 76.37% 76.37% 76.38%
No. of Shareholders 11,33111,30311,43211,37111,34211,36012,22012,42612,76612,96313,30713,583

Documents

Announcements

Annual reports